VISTN — Vistin Pharma ASA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	—	—	—	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	253	276	288	435	430
Cost of Revenue
Gross Profit	180	180	150	259	280
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	208	243	294	367	344
Operating Profit	45.6	33.3	-6.09	68.6	85.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-124	32	-6.01	58.5	80.5
Provision for Income Taxes
Net Income After Taxes	-97	24.9	-4.71	45.6	62.7
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-97	24.9	-4.71	45.6	62.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-97	24.9	-4.72	45.6	64.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-2.19	0.561	-0.106	1.03	1.45
Dividends per Share